
WHY CHOOSE Limosilactobacillus reuteri capsules ?
Limosilactobacillus reuteri capsules - from valuable lactic acid bacteria
Our capsules contain the unique Limosilactobacillus reuteri DSM17648 strain, derived from a natural lactic acid bacterium. Taking two capsules daily provides you with 20 billion (400 mg) of Lactobacillus reuteri DSM17648 (inactivated).
Limosilactobacillus reuteri contains an inactivated Limosilactobacillus reuteri strain for the dietary management of gastric mucosal inflammation caused by Helicobacter pylori infection. The bacterial lysate can specifically bind Helicobacter pylori in the stomach and cause it to be excreted.
Quality monitored and guaranteed through continuous analysis.
Suitable for diabetics. The information provided does not constitute a therapeutic claim or an encouragement for self-medication. Important information: Dietary management of Helicobacter pylori.
Food for special medical purposes (balanced diet) for the dietary management of Helicobacter pylori infections.
PylopassTM is a trademark of Novozymes A/S Denmark – www.pylopass.com.
SUBSCRIPTION
INGREDIENTS
VALEURS NUTRITIONNELLES MOYENNES
* in % of the nutrient reference value (NRV) according to: EU 1169 / 2011.